Skip to main content

CASE REPORT article

Front. Pediatr.
Sec. Neonatology
Volume 12 - 2024 | doi: 10.3389/fped.2024.1474192

Aortoiliac arterial thrombosis and renal artery stenosis in a patient with neonatal multisystem inflammatory syndrome: A Case Report and Review of Literature

Provisionally accepted
Oranooj Lertkovit Oranooj Lertkovit 1*Daranee Isaranimitkul Daranee Isaranimitkul 1Suwanna Pornrattanarungsri Suwanna Pornrattanarungsri 2Ornatcha Sirimongkolchaiyakul Ornatcha Sirimongkolchaiyakul 3Sirikarn Tangcheewinsirikul Sirikarn Tangcheewinsirikul 4Pichada Saengrat Pichada Saengrat 5
  • 1 Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
  • 2 Division of Cardiology, Department of Pediatrics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
  • 3 Division of Nephrology, Department of Pediatrics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
  • 4 Division of Rheumatology, Department of Pediatrics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
  • 5 Division of Neonatology, Department of Pediatrics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand

The final, formatted version of the article will be published soon.

    Background: Multisystem inflammatory syndrome in neonates (MIS-N) is a rare condition proposed to be associated with prenatal exposure to maternal severe acute respiratory syndrome coronavirus 2 infection. This immune-mediated hyperinflammation has been described in neonates with multiorgan dysfunction, including cardiopulmonary, encephalopathy, coagulopathy, and vascular complications.However, renovascular complications in MIS-N are rare. Here, we present a case with aortoiliac arterial thrombosis and renovascular stenosis in MIS-N.Case Presentation: A 2-day-old full-term male neonate presented with fever, respiratory failure, hypotensive shock, and elevated inflammatory markers. He was transferred to our neonatal intensive care unit for comprehensive monitoring and treated with antibiotics for early-onset neonatal sepsis.However, his clinical condition deteriorated. His mother reported a history of severe acute respiratory syndrome coronavirus 2 infection during the late second trimester. He was diagnosed with MIS-N based on the fulfillment of the diagnostic criteria for multiorgan involvement and laboratory findings.He responded to intravenous immunoglobulin, corticosteroids, and aspirin. However, he later developed significant hypertension, which was associated with aortoiliac arterial thrombosis and right renal artery stenosis. Elevated ferritin level was observed. The ongoing inflammatory condition was considered, and corticosteroids was restarted along with treatment for documented thrombosis using enoxaparin and aspirin. Following treatment, partial resolution of aortoiliac arterial thrombus was observed. However, narrowing of the proximal part of right renal artery persisted, and blood pressure remained difficult to control, requiring multiple antihypertensive agents. Finally, the patient underwent percutaneous transluminal balloon angioplasty to control hypertension.Our case revealed the clinical course of MIS-N with renovascular complications. The condition's hyperinflammatory state may have played a pathophysiological role in the development of this life-threatening complication. Although there is an increased risk of bleeding in MIS-N, thromboprophylaxis should be considered in high-risk patients. An early multidisciplinary approach 44 is recommended to ensure prompt diagnosis and improve outcomes. 4

    Keywords: MIS-N, case report, Neonatal hypertension, Thrombosis, SARS-CoV-2

    Received: 01 Aug 2024; Accepted: 18 Dec 2024.

    Copyright: © 2024 Lertkovit, Isaranimitkul, Pornrattanarungsri, Sirimongkolchaiyakul, Tangcheewinsirikul and Saengrat. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Oranooj Lertkovit, Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.